Background: collagen vascular diseases (CVDs) are well known causes of pulmonary involvement, leading to significant morbidity. The purpose of this study was to identify several thoracic computed tomographic findings of CVDs.
INTRODUCTION
Collagen vascular diseases refer to a group of autoimmune disorders including rheumatoid arthritis (RA), systemic lupus erythematous (SLE), scleroderma, polymyositis/dermatomyositis and mixed connective tissue disease (MCTD) (1) . These multisystemic diseases affect a number of organs such as kidneys, joints, skin, serous membrane, the lungs and the vascular and nervous systems.
Pleural and pulmonary involvements are detected in all
CVDs to some degrees (2) . In addition, pulmonary involvement is known as the leading cause of morbidity and mortality in CVDs (3) .
TANAFFOS 44 CT Findings of Collagen Vascular Diseases
Tanaffos 2014; 13 (1) : [43] [44] [45] [46] [47] Imaging modalities play a significant role in diagnosis of thoracic diseases. Thoracic manifestations of CVDs contain those of parenchyma (interstitial pneumonia), airways (bronchiectasis and upper respiratory track diseases), pleura (pleural effusion and pneumothorax), vascular system (pulmonary hypertension and pulmonary arthritis), secondary disorders (drug complication, infection and malignancy) and several other conditions (4).
CT scan is the most popular cross sectional method for chest imaging; however, high-resolution computed tomography (HRCT) is the selective imaging technique for diagnosis of pulmonary fibrosis, interstitial lung diseases and bronchiectasis (5) .
Knowledge about thoracic imaging findings of CVDs can lead to early diagnosis and consequently decrease the hospital stay and improve treatment efficacy. The purpose of this study was to identify several thoracic computed tomographic findings of CVDs. Regarding the site of involvement, parenchyma was the most common among each group whereas airways in SLE (11.7%), vascular system in RA (11.7%), pleura in scleroderma (38.8%) and airways and vascular system in MCDT (33.3%) demonstrated the lowest prevalence rate.
MATERIALS AND METHODS
Generally, parenchyma and vascular system were reported to be the most and the least common site of involvement, respectively. Table 2 shows these data in details. 
DISCUSSION
We assessed 56 CVD patients and their CT findings were interpreted. Lung parenchyma showed the highest involvement (96.4%), mostly presented in mixed (55.3%) and peripheral pattern (41.7%).
In a study by Lim and colleagues on 23 CVID patients, sub pleural involvement was the most common finding (90%). This difference with our result may be due to wide range of diseases in our study including those with diffuse parenchymal involvement (6).
Furthermore, the most common pattern in our study was reticular pattern (55.3%) versus ground glass opacity in their study (57%). However, GGO occurred in 50% of our cases, similarly (6).
Tanaka and colleagues (7) Pleura has been mentioned as the most common involved site in RA in the study by Mayberry and colleagues while we found parenchyma as the most common site. Considering that our cases were all hospitalized, this difference may be resulted from higher morbidity of parenchyma in our cases. Therefore, it is suggested to undertake further evaluations to achieve more accurate results in this regard (8).
Mayberry and colleagues reported 91% pulmonary fibrosis prevalence in their study of 23 scleroderma patients but another study showed 20-65 % prevalence of pulmonary fibrosis (8 Concerning SLE, Lalani and colleagues mentioned pleural involvement as the most common finding (9) whereas we found parenchymal involvement as the most common finding (88.2%). Similar to RA group, hospitalization is assumed to be a contributory factor and it is necessary to carry out more studies to assess the morbidity rate of parenchymal involvement in SLE. On the other hand, Tanaka and colleagues found UIP to be a rare finding in SLE, which is similar to our result (n=0) (10).
Among polymyositis/dermatomyositis cases, we observed only one case with obliterative bronchiolitis; whereas in the study by Tanaka NSIP was reported to be the most common finding (10). Mino and colleagues mentioned pulmonary involvement as the most common finding (11) . Small number of polymyositis/dermatomyositis cases in our study may be responsible for the low rate of pulmonary involvement.
A combination of reticular pattern, peripheral subpleural interlobular septal thickening and ground glass opacity is seen in the majority of patients with CVDs. The results indicate that obliterative bronchiolitis is more prevalent than what has been reported in previous studies.
CT manifestations of pulmonary fibrosis in our study were similar to those of most other studies.
